Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Intellia Therapeutics Inc

Intellia Therapeutics Inc

NTLA · NASDAQ
NTLA · NASDAQ

Next Earnings: 06 Aug 2026

12.61
USD-0.46-3.52%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW! Rebel's Edge 1pm Stocks: NTLA HUM UNH HCA GLW 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarianOnly 4 jobs remain in NFL What is the best to worst jobs left? Who is the MVP?Stafford, Maye, or someone else? https://t.co/WLtlSP07N9

      @DeItaone
      DeItaone

      Coverage Initiated $EDIT $GIS $NTLA $RCKT $ROL $SHOP $VERV https://t.co/HsvywOztkC https://t.co/vPxyRE3iIJ

        @DeItaone
        DeItaone

        Upgrades https://t.co/eAzzXmW2uv $BX $HASI $IBM $LYFT $MRO $NTLA $XYL https://t.co/c9MtCpeWvz

          @cryptomocho
          cryptomocho

          added only bio stunks to my porfolio and tesla $NTLA $BEAM $CRSP $EDIT $VERV $DNA $ADAP and my bigest one $intx https://t.co/jy9Q2ROAnB

            SeekingAlpha

            Intellia Therapeutics, Alnylam seen as potential Regeneron targets, analyst says

              CNBC

              Stocks making the biggest moves in the premarket: Boeing, Intellia Therapeutics, Perion Network & more - CNBC

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              12.24USD
              12.87USD

              52 Week Range

              6.83USD
              28.25USD

              Market Cap

              1.76BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US45826J1051

              CUSIP

              45826J105

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -0.10

              Book Value

              5.16

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -3.52

              Wall Street Target Price

              26.63

              EPS Estimate Current Year

              -3.17

              EPS Estimate Next Year

              -1.85

              EPS Estimate Current Quarter

              -0.8981

              EPS Estimate Next Quarter

              -0.8719

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              66,092,000

              Gross Profit TTM

              -230,670,000

              EBITDA

              -411,244,000

              Profit Margin

              0.00%

              Return On Assets TTM

              -30.14%

              Return On Equity TTM

              -56.34%

              Revenue Per Share TTM

              0.589

              Qtly Revenue Growth YOY

              -9.50%

              Diluted Eps TTM

              -3.52

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              26.32

              Price Book MRQ

              2.8352

              Enterprise Value Revenue

              22

              Enterprise Value EBITDA

              -5

              Peers analysis

              • UCB SA
                UCBJFUCB SA

                289.84

                7.21%
              • CSL Limited
                CMXHFCSL Limited

                72.60

                4.81%
              • Revolution Medicines Inc
                RVMDRevolution Medicines Inc

                154.89

                3.58%
              • UCB SA ADR
                UCBJYUCB SA ADR

                142.12

                1.26%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                295.50

                0.74%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                634.62

                -10.96%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                435.93

                -3.25%
              • argenx NV ADR
                ARGXargenx NV ADR

                808.43

                -1.62%
              • CSL Ltd
                CSLLYCSL Ltd

                17.46

                -1.30%
              • Be
                ONCBeiGene, Ltd.

                302.44

                -0.69%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Intellia Therapeutics stock price today?

              What is Intellia Therapeutics stock ticker?

              Is NTLA stock price going up?

              What is the analyst recommendation for NTLA?

              What is NTLA market cap?

              Does NTLA release financial reports?

              When is NTLA next earnings date?

              What were NTLA Earnings for the last quarter?

              What was NTLA Revenue for the last quarter?

              What was NTLA Net Income for the last quarter?

              Does NTLA pay dividends?

              How many employees does NTLA have?

              What is NTLA EBITDA?

              How to buy NTLA stocks?

              Should I invest in NTLA stock?